CA3143308C - Application de glucane dans la preparation d'un medicament - Google Patents

Application de glucane dans la preparation d'un medicament

Info

Publication number
CA3143308C
CA3143308C CA3143308A CA3143308A CA3143308C CA 3143308 C CA3143308 C CA 3143308C CA 3143308 A CA3143308 A CA 3143308A CA 3143308 A CA3143308 A CA 3143308A CA 3143308 C CA3143308 C CA 3143308C
Authority
CA
Canada
Prior art keywords
glucan
antibody
cancer
tumor
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3143308A
Other languages
English (en)
Other versions
CA3143308A1 (fr
Inventor
Jinbo Yang
Guangli YU
Qiaoling SONG
Lijuan WU
Jun Zhao
Youjing LV
Chenyang ZHAO
Huashi Guan
Original Assignee
Qingdao Conson Pharmaceutical Co Ltd
Qingdao Marine Biomedical Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201910512814.6A external-priority patent/CN112076208A/zh
Application filed by Qingdao Conson Pharmaceutical Co Ltd, Qingdao Marine Biomedical Research Institute Co Ltd filed Critical Qingdao Conson Pharmaceutical Co Ltd
Publication of CA3143308A1 publication Critical patent/CA3143308A1/fr
Application granted granted Critical
Publication of CA3143308C publication Critical patent/CA3143308C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne une application d'un glucane dans la préparation d'un médicament. Un bêta-1,3/1,6-glucane est utilisé pour préparer une composition ou une formulation pharmaceutique. La composition ou la formulation pharmaceutique peut améliorer l'effet antitumoral d'une immunothérapie, d'une radiothérapie ou d'une chimiothérapie, et est utilisée pour traiter la leucopénie et/ou la thrombocytopénie.
CA3143308A 2019-06-13 2020-06-15 Application de glucane dans la preparation d'un medicament Active CA3143308C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910512814.6 2019-06-13
CN201910512814.6A CN112076208A (zh) 2019-06-13 2019-06-13 一种葡聚糖在制备药物的应用
PCT/CN2020/096223 WO2020249132A1 (fr) 2019-06-13 2020-06-15 Application de glucane dans la préparation d'un médicament

Publications (2)

Publication Number Publication Date
CA3143308A1 CA3143308A1 (fr) 2020-12-17
CA3143308C true CA3143308C (fr) 2026-01-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024201840B2 (en) Application of glucan in preparation of drug
US9211304B2 (en) Therapy-enhancing glucan
US20130289101A1 (en) Therapy-enhancing glucan
US12533373B2 (en) β-glucan composition and use therefor
Rui et al. pH-responsive polymeric nanoparticles for peptide delivery: Synergistic STING pathway activation enhances tumor immunotherapy
EP4029509A1 (fr) Composition pour augmenter l'effet d'un médicament de type anticorps
CA3143364C (fr) Composition de .beta.-glucane et son utilisation
KR20150131671A (ko) 금사린테우산을 주성분으로 하는 주사제용 항암제 조성물 및 그 제조방법
CN119424668A (zh) β-葡聚糖抗体药物偶联物、制备方法及免疫抗肿瘤应用
CN117024626A (zh) 一类新型α-葡聚糖及其用途
CN113797221A (zh) 一种β-葡聚糖组合物及其用途